Loading company…
Northstar Neuroscience develops neurological diagnostic and therapeutic products for healthcare providers and institutions.
Northstar Neuroscience develops neurodiagnostic tools and therapeutic devices for neurological conditions. The company went public in May 2006, raising USD 113.9 mn. It is based in Shoreline, US, and is listed at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in